Search
CareDx Inc
CDNAAdd to Watchlist
46.690USD
+1.880+4.20%
Close 08-07 16:00（ET）Quotes delayed by 15 min
2.40BMarket Cap
LossP/E TTM
Forecast
Currency: USD Updated: 2026-08-07The current earnings forecast score of CareDx Inc is 7.71, ranking 270 out of 387 in the Biotechnology & Medical Research industry. The average price target is 24.50, with a high of 28.00 and a low of 14.00.
Analyst Rating
Based on
7
analysts
Buy
Current Rating
52.333
Target Price
+16.79%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
497
Total
6
Median
7
Average
Company name
Ratings
Analysts
CareDx Inc
CDNA
7
argenx SE
ARGX
28
Beigene Ltd
ONC
28
Ionis Pharmaceuticals Inc
IONS
25
Insmed Inc
INSM
24
Kymera Therapeutics Inc
KYMR
23
1
2
3
...
100
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is CareDx Inc's expected revenue for the next quarter?
CareDx Inc's expected revenue is 119.15M.
What is CareDx Inc's price target?
Analysts forecast that CareDx Inc's price target is USD 24.50, with the highest forecast at USD 28.00 and the lowest forecast at USD 14.00.
How have CareDx IncCDNA's recent earnings per share performed?
The market expectation was USD 2.15, while CareDx IncCDNA's earnings per share (EPS) for the previous quarter was USD 0.05. EPS for the next quarter is expected at USD 0.24.
What is the analyst rating for CareDx Inc?
Based on the ratings of CareDx Inc's stock from 7 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.